Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Testosterone and the prostate].

H Sperling1, R Rossi, G Lümmen

  • 1Urologische Klinik, Universitätsklinikum, Essen. herbert.sperling@uni-essen.de

Der Urologe. Ausg. A
|September 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Der Urologe. Ausg. A·2020
Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020
Same author

[Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association].

Der Urologe. Ausg. A·2020
Same author

[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].

Der Urologe. Ausg. A·2018
Same author

[Incontinence].

Der Urologe. Ausg. A·2017
Same author

[Artificial urinary sphincter in women-too uncommon?]

Der Urologe. Ausg. A·2017
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Testosterone therapy appears safe for the prostate, with no significant increase in prostate cancer risk. Regular monitoring is recommended, especially for hypogonadal men with high-grade PIN.

Area of Science:

  • Urology
  • Endocrinology
  • Oncology

Context:

  • Testosterone plays a crucial role in both benign and malignant prostate diseases.
  • Understanding testosterone's physiological interactions with the prostate is vital for urologists.
  • Special considerations exist for testosterone substitution therapy in men with prostate conditions.

Purpose:

  • To evaluate the safety and impact of testosterone substitution therapy on prostate health.
  • To determine changes in prostate-specific antigen (PSA) levels and prostate volume during therapy.
  • To assess the risk of prostate carcinoma in men undergoing testosterone substitution.

Summary:

  • Testosterone substitution therapy does not significantly alter PSA values or prostate volume.
  • Current evidence suggests the therapy is safe with regular prostate monitoring (PSA and sonography), not increasing prostate carcinoma risk.

Related Experiment Videos

  • In hypogonadal men with high-grade prostatic intraepithelial neoplasia (PIN), 1 in 20 showed carcinoma upon suspicious rectal examination, irrespective of PSA levels.

    • Impact:

    • Provides crucial insights for urologists managing patients on testosterone therapy.
    • Suggests testosterone substitution can be safely administered with appropriate monitoring.
    • Highlights the need for further research regarding testosterone substitution post-prostatectomy.